In 2017, the legal department at Ortho Clinical Diagnostics played a key role in the evolution of the $1.8 billion in vitro diagnostics company, acquiring a Brazil operation and completing a three-year process of transitioning to private equity ownership from former parent company Johnson & Johnson. The group handled various other matters, including negotiation of a $200 million credit line increase and preparation for the European Union’s General Data Protection Regulation. Three of the Ortho legal department’s eight lawyers, and 14 of its 22 total professionals, are based in Raritan.

** The responses were provided by Michael Schlesinger, executive vice president, general counsel and secretary at Ortho Clinical Diagnostics. **